Krystal Biotech, Inc. (KRYS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 7.14B |
| Enterprise Value | 6.65B |
| P/E Ratio | 44.31 |
| PEG Ratio | 0.56 |
| Price/Sales Ratio | 24.26 |
| Price/Book Ratio | 7.88 |
| Enterprise/Revenue | 23.08 |
| Enterprise/EBITDA | 48 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.54 |
| Operating Margin | 0.43 |
| Return On Assets | 0.16 |
| Return On Equity | 0.19 |
| Revenue | 389.13M |
| Revenue/Share | 14.25 |
| Gross Profit | 360.36M |
| EBITDA | 196.02M |
| Net Income | 204.83M |
| Diluted EPS | 6.84 |
| Total Cash | 823.41M |
| Total Cash/Share | 28.11 |
| Total Debt | 9.11M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 9.46 |
| Book Value Per Share | 43.59 |
| 52-Week Change | 149.01 |
| 52-Week High | 356.5 |
| 52-Week Low | 130.5 |
| Moving Average 50 Days | 295.73 |
| Moving Average 200 Days | 245.16 |
| Average Volume | 295,991 |
| Shares Outstanding | 29.48M |
| % Held by Institutions | 98.01 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |